Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 778 is a transcription factor belonging to the Krueppel C2H2-type zinc-finger protein family, characterized by a KRAB domain and eighteen C2H2-type zinc fingers[1][3][5]. It regulates gene expression through sequence-specific DNA binding, is implicated as a candidate gene in autism and cognitive impairment associated with the 16q24.3 microdeletion syndrome, and may play roles in cancer biology and immunity based on functional knockout models[1][3][7]. Evidence for drug interactions, clinical targeting, or use as a biomarker in therapeutic settings is lacking in current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 778 (ZNF778).